PharmaregUAE

Compounding Pharmacy Regulation in the UAE Under the Current Law

8 min read Published 5 June 2026

The 2025 pharmaceutical law moved most federal drug regulation to the Emirates Drug Establishment (EDE), but it did not move everything. Compounding pharmacy licensing stayed with the Ministry of Health and Prevention (MOHAP). This explainer sets out who regulates what under the current law, and where a compounding operation still meets the EDE.

The 2025 law redrew the regulatory map

Under the UAE pharmaceutical law in force from 2025, the EDE became the federal authority for pharmaceutical facility licensing (including medical warehouses and drug stores), product classification, product registration and marketing authorisation, manufacturing site registration, import and export permits, and GMP, GDP, and GSP oversight. These functions transferred from MOHAP.

That sentence covers most of the industry, but not all of it. The law left specific pharmacy-level functions where they were, and compounding pharmacies sit squarely inside that carve-out.

For operators who grew up under the previous arrangement, the practical adjustment is a split map. The licence that lets you compound and dispense sits in one system; the rules that govern products, imported ingredients, and wholesale facilities sit in another. Neither replaces the other, and both apply at once.

What MOHAP retains

MOHAP retains community and compounding pharmacy licensing and certain narcotics controls. For a compounding pharmacy, the operating licence therefore remains a MOHAP matter, not an EDE one. The wider authority map is worth keeping in view, because a single operation can touch several regulators at once.

The split

Who regulates what under the current law

  • EDE: product registration and classification, manufacturing site registration, import and export permits, facility licensing for medical warehouses and drug stores, GMP/GDP/GSP oversight
  • MOHAP: community pharmacy licensing, compounding pharmacy licensing, certain narcotics controls
  • DHA (Sheryan portal): Dubai health facilities, telehealth, and home healthcare
  • Dubai Municipality (Montaji portal): cosmetics and consumer products in Dubai

Knowing which door to knock on is half the compliance work. Applications addressed to the wrong authority lose time before they lose anything else. In Dubai, a clinic or health facility attached to the operation answers to the DHA through the Sheryan portal, while consumer products sold alongside sit with Dubai Municipality's Montaji system.

Where a compounding operation still meets the EDE

A compounding pharmacy is MOHAP-licensed, but its supply chain is not MOHAP-regulated. Only entities holding a UAE pharmaceutical facility or medical warehouse licence with the corresponding EDE import permit may import pharmaceuticals and active pharmaceutical ingredients (APIs). Imported ingredients therefore reach a compounding pharmacy through a licensed importer holding an EDE permit, not through the pharmacy's own licence.

Classification is also an EDE function. Where it is unclear how a product or ingredient is categorised, classification is the first step before anything is imported or registered. And any storage or wholesale activity beyond the pharmacy licence itself, such as a medical warehouse or drug store supplying multiple sites, falls under EDE facility licensing.

The registered medicines a pharmacy purchases and dispenses alongside its compounded preparations also trace back to the EDE, which now grants product registration and marketing authorisation. Those registrations, like manufacturing site registrations, are each valid for 5 years.

What operators should check now

  • Keep the pharmacy licence and its renewals with MOHAP, as before
  • Source imported pharmaceuticals and APIs only through licensed importers holding EDE import permits
  • Where narcotics or controlled materials are involved, expect MOHAP controls to continue applying
  • Where the operation includes a medical warehouse or drug store, that facility licence sits with the EDE
  • Where a product's category is unclear, obtain an EDE classification before committing to a pathway

None of these checks is difficult in isolation. The friction appears when one project, a new branch with a central store for example, needs MOHAP licensing, EDE facility licensing, and permitted importation at the same time. Sequencing the three, and knowing which authority answers which question, is where an experienced partner saves the calendar.

We work both sides of this split. Our pharmaceutical facility licensing service covers new licences, renewals, and variations across warehouse and pharmacy operations, with the correct authority addressed at each step.

Frequently asked questions

Who licenses compounding pharmacies in the UAE?
MOHAP. Under the current law, MOHAP retains community and compounding pharmacy licensing, along with certain narcotics controls, while most other federal pharmaceutical functions moved to the EDE.
Did the EDE take over pharmacy licensing in 2025?
No. The EDE took over facility licensing for medical warehouses and drug stores, product registration, classification, import and export permits, and GMP, GDP, and GSP oversight. Community and compounding pharmacy licensing stayed with MOHAP.
Can a compounding pharmacy import APIs directly?
Only entities holding a UAE pharmaceutical facility or medical warehouse licence with the corresponding EDE import permit may import pharmaceuticals and APIs. In practice, imported ingredients come through a licensed importer holding that permit.

Explore our facility licensing service

This explainer is general information, not regulatory or legal advice. Requirements evolve as the UAE authorities update their processes; confirm current rules with the relevant authority or contact our team before acting.

Licensing or renewing a pharmacy operation?

Send us the product details and we will come back with a roadmap, classification opinion, and indicative timeline within 48 hours.

Talk to our team